Clinical trial
A Semi-Quantitative and Comparative Study for the Detection of Group A β-Hemolytic Streptococci in Oral Samples
NCT05223634 is registered in ClinicalTrials.gov with Hero Scientific as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Semi-Quantitative and Comparative Study for the Detection of Group A β-Hemolytic Streptococci in Oral Samples
- Lead sponsor
- Hero Scientific
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 18, 2020
- Completion date
- June 30, 2022
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
group a β-hemolytic streptococci